305 related articles for article (PubMed ID: 33614502)
1. Targeting Lactate Metabolism by Inhibiting MCT1 or MCT4 Impairs Leukemic Cell Proliferation, Induces Two Different Related Death-Pathways and Increases Chemotherapeutic Sensitivity of Acute Myeloid Leukemia Cells.
Saulle E; Spinello I; Quaranta MT; Pasquini L; Pelosi E; Iorio E; Castelli G; Chirico M; Pisanu ME; Ottone T; Voso MT; Testa U; Labbaye C
Front Oncol; 2020; 10():621458. PubMed ID: 33614502
[TBL] [Abstract][Full Text] [Related]
2. The small-molecule compound AC-73 targeting CD147 inhibits leukemic cell proliferation, induces autophagy and increases the chemotherapeutic sensitivity of acute myeloid leukemia cells.
Spinello I; Saulle E; Quaranta MT; Pasquini L; Pelosi E; Castelli G; Ottone T; Voso MT; Testa U; Labbaye C
Haematologica; 2019 May; 104(5):973-985. PubMed ID: 30467201
[TBL] [Abstract][Full Text] [Related]
3. Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis.
Van der Vreken A; Oudaert I; Ates G; Faict S; Vlummens P; Satilmis H; Fan R; Maes A; Massie A; De Veirman K; De Bruyne E; Vanderkerken K; Menu E
J Pathol; 2023 Jun; 260(2):112-123. PubMed ID: 36807305
[TBL] [Abstract][Full Text] [Related]
4. Glucose-dependent growth arrest of leukemia cells by MCT1 inhibition: Feeding Warburg's sweet tooth and blocking acid export as an anticancer strategy.
Pivovarova AI; MacGregor GG
Biomed Pharmacother; 2018 Feb; 98():173-179. PubMed ID: 29253765
[TBL] [Abstract][Full Text] [Related]
5. Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells.
Benjamin D; Robay D; Hindupur SK; Pohlmann J; Colombi M; El-Shemerly MY; Maira SM; Moroni C; Lane HA; Hall MN
Cell Rep; 2018 Dec; 25(11):3047-3058.e4. PubMed ID: 30540938
[TBL] [Abstract][Full Text] [Related]
6. Cellular Uptake of MCT1 Inhibitors AR-C155858 and AZD3965 and Their Effects on MCT-Mediated Transport of L-Lactate in Murine 4T1 Breast Tumor Cancer Cells.
Guan X; Rodriguez-Cruz V; Morris ME
AAPS J; 2019 Jan; 21(2):13. PubMed ID: 30617815
[TBL] [Abstract][Full Text] [Related]
7. Monocarboxylate Transporters MCT1 and MCT4 Regulate Migration and Invasion of Pancreatic Ductal Adenocarcinoma Cells.
Kong SC; Nøhr-Nielsen A; Zeeberg K; Reshkin SJ; Hoffmann EK; Novak I; Pedersen SF
Pancreas; 2016 Aug; 45(7):1036-47. PubMed ID: 26765963
[TBL] [Abstract][Full Text] [Related]
8. AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7-10.
Ovens MJ; Davies AJ; Wilson MC; Murray CM; Halestrap AP
Biochem J; 2010 Jan; 425(3):523-30. PubMed ID: 19929853
[TBL] [Abstract][Full Text] [Related]
9. Identification of key binding site residues of MCT1 for AR-C155858 reveals the molecular basis of its isoform selectivity.
Nancolas B; Sessions RB; Halestrap AP
Biochem J; 2015 Feb; 466(1):177-88. PubMed ID: 25437897
[TBL] [Abstract][Full Text] [Related]
10. In Vitro and In Vivo Efficacy of the Monocarboxylate Transporter 1 Inhibitor AR-C155858 in the Murine 4T1 Breast Cancer Tumor Model.
Guan X; Bryniarski MA; Morris ME
AAPS J; 2018 Nov; 21(1):3. PubMed ID: 30397860
[TBL] [Abstract][Full Text] [Related]
11. Targeting the monocarboxylate transporter MCT2 and lactate dehydrogenase A LDHA in cancer cells with FX-11 and AR-C155858 inhibitors.
Alobaidi B; Hashimi SM; Alqosaibi AI; AlQurashi N; Alhazmi S
Eur Rev Med Pharmacol Sci; 2023 Jul; 27(14):6605-6617. PubMed ID: 37522672
[TBL] [Abstract][Full Text] [Related]
12. Targeted sensitization of tumor cells for radiation through monocarboxylate transporters 1 and 4 inhibition in vitro.
Brandstetter G; Blatt S; Goldschmitt J; Taylor L; Heymann P; Al-Nawas B; Ziebart T
Clin Oral Investig; 2021 Jan; 25(1):295-310. PubMed ID: 32495222
[TBL] [Abstract][Full Text] [Related]
13. MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis.
Lee JY; Lee I; Chang WJ; Ahn SM; Lim SH; Kim HS; Yoo KH; Jung KS; Song HN; Cho JH; Kim SY; Kim KM; Lee S; Kim ST; Park SH; Lee J; Park JO; Park YS; Lim HY; Kang WK
Oncotarget; 2016 Jul; 7(28):43492-43503. PubMed ID: 27224918
[TBL] [Abstract][Full Text] [Related]
14. The expression of lactate transporters (MCT1 and MCT4) in heart and muscle.
Bonen A
Eur J Appl Physiol; 2001 Nov; 86(1):6-11. PubMed ID: 11820324
[TBL] [Abstract][Full Text] [Related]
15. Monocarboxylate transporter 1 and 4 inhibitors as potential therapeutics for treating solid tumours: A review with structure-activity relationship insights.
Puri S; Juvale K
Eur J Med Chem; 2020 Aug; 199():112393. PubMed ID: 32388280
[TBL] [Abstract][Full Text] [Related]
16. Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
Kim Y; Choi JW; Lee JH; Kim YS
Hum Pathol; 2015 Jan; 46(1):104-12. PubMed ID: 25456395
[TBL] [Abstract][Full Text] [Related]
17. Monocarboxylate transporters MCT1 and MCT4 are independent prognostic biomarkers for the survival of patients with clear cell renal cell carcinoma and those receiving therapy targeting angiogenesis.
Cao YW; Liu Y; Dong Z; Guo L; Kang EH; Wang YH; Zhang W; Niu HT
Urol Oncol; 2018 Jun; 36(6):311.e15-311.e25. PubMed ID: 29657088
[TBL] [Abstract][Full Text] [Related]
18. MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.
Hong CS; Graham NA; Gu W; Espindola Camacho C; Mah V; Maresh EL; Alavi M; Bagryanova L; Krotee PAL; Gardner BK; Behbahan IS; Horvath S; Chia D; Mellinghoff IK; Hurvitz SA; Dubinett SM; Critchlow SE; Kurdistani SK; Goodglick L; Braas D; Graeber TG; Christofk HR
Cell Rep; 2016 Feb; 14(7):1590-1601. PubMed ID: 26876179
[TBL] [Abstract][Full Text] [Related]
19. Organized metabolic crime in prostate cancer: The coexpression of MCT1 in tumor and MCT4 in stroma is an independent prognosticator for biochemical failure.
Andersen S; Solstad Ø; Moi L; Donnem T; Eilertsen M; Nordby Y; Ness N; Richardsen E; Busund LT; Bremnes RM
Urol Oncol; 2015 Aug; 33(8):338.e9-17. PubMed ID: 26066969
[TBL] [Abstract][Full Text] [Related]
20. Monocarboxylate transporter 1 (MCT1), a tool to stratify acute myeloid leukemia (AML) patients and a vehicle to kill cancer cells.
Lopes-Coelho F; Nunes C; Gouveia-Fernandes S; Rosas R; Silva F; Gameiro P; Carvalho T; Gomes da Silva M; Cabeçadas J; Dias S; Gonçalves LG; Serpa J
Oncotarget; 2017 Oct; 8(47):82803-82823. PubMed ID: 29137304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
